From RORγt Agonist to Two Types of RORγt Inverse Agonists
Yonghui Wang(Weifang People's Hospital), Feng Ren(Henan Medical University), Yafei Huang(University of Denver), Liming Shao(Fudan University), Mercedes Lobera(GlaxoSmithKline (United Kingdom)), Lisa A. Orband‐Miller(GlaxoSmithKline (China)), Yingli Ma(GlaxoSmithKline (China)), Qianqian Wu(GlaxoSmithKline (China)), Qian Liu(Guangxi Medical University), Xichen Lin(GlaxoSmithKline (China)), Wei Cai(GlaxoSmithKline (China)), Liuqing Yang(GlaxoSmithKline (China)), Ling Zhou(China Pharmaceutical University), Guifeng Zhang(GlaxoSmithKline (China)), Ting Tang(Fudan University), Stewart Leung(GlaxoSmithKline (China)), Zhijun Xiang(GlaxoSmithKline (China)), Jia‐Ning Xiang(GlaxoSmithKline (China)), Ting Yang(GlaxoSmithKline (China)), Xiaoxia Song(Fudan University)
Cited by 30
Related Papers
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
|Journal of Chemical Information and Modeling|2023|196
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
|Molecular Cancer|2009|131
PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
|Journal of Chemical Information and Modeling|2024|125